SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs large equity offering and stock-funded Elisity acquisition have put dilution, capital allocation, and execution risk at the center of the discussion as shares sell off. Some traders see the deals as building a broader quantum-computing, networking, and security platform, while others doubt the strategy will create value per share and are focused on upcoming results for evidence of progress.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA accelerated approval of a competing treatment for recurrent respiratory papillomatosis has raised concerns about competition for Precigens PAPZIMEOS. Traders debate whether the rivals dosing regimen will draw demand away or whether PAPZIMEOS commercial head start and established market access will help it retain an advantage, while also watching Precigens upcoming earnings.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Attention centers on Alpha Taus oncology pipeline and a packed clinical catalyst calendar, including the FDA-expanded REGAIN glioblastoma study, completed enrollment in its expanded pancreatic cancer trial, and a possible U.S. Keytruda-combination trial. Traders are broadly bullish on the trial progress and upcoming data, though some are waiting for official updates and larger datasets before treating early results as proof.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

Centrus shares are drawing attention amid a steep selloff, with traders frequently blaming share and warrant issuance and worrying about further dilution. Bulls argue the financing supports the companys domestic uranium-enrichment expansion and point to a reported first centrifuge shipment, while bears question the valuation and how quickly that growth can translate into results.

Algorand (ALGO) is a cryptocurrency launched in 2019. Algorand has a current supply of 10,000,000,000 with 9,076,179,334.339727 in circulation. The last known price of Algorand is 0.09376203 USD and is down -1.34 over the last 24 hours. It is currently trading on 586 active market(s) with $49,710,890.79 traded over the last 24 hours. More information can be found at http://algorand.foundation.

Algorand

ALGOs steep long-term decline and weak price action are driving a split between traders calling for further losses and holders arguing that a bottom may be forming ahead of an altcoin recovery. Bulls point to Algorands post-quantum upgrades and potential payments and tokenization use cases, while bears cite limited adoption, token-supply pressure and persistent underperformance.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons strong third-quarter earnings beat is driving attention, with growth in Dupixent and Eylea HD helping offset pressure on legacy Eylea. Traders reacted to the report with a sharp rally and bullish options positioning, while some remain focused on biosimilar competition and the decline in legacy Eylea sales.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarnas prolonged share-price slide after its recent earnings and guidance concernsparticularly weaker German-market expectations and continued investment spendingdominates discussion ahead of the next report. Traders are frustrated by persistent selling, with some blaming shorting or manipulation, while bullish investors view the weakness as a buying opportunity based on partnerships and longer-term growth prospects.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXTs strong quarterly results and above-consensus outlook are the main focus, with traders highlighting accelerating indium phosphide demand tied to AI data-center optics. Shares nevertheless sold off, prompting debate over whether broad tech-sector weakness and volatility are outweighing the upbeat fundamentals or signaling more downside.

Stellar (XLM) is a cryptocurrency launched in 2014. Stellar has a current supply of 50,001,786,837.39707 with 35,251,440,068.9505 in circulation. The last known price of Stellar is 0.16728777 USD and is down -1.15 over the last 24 hours. It is currently trading on 848 active market(s) with $82,083,533.38 traded over the last 24 hours. More information can be found at https://www.stellar.org.

Stellar Lumens

Persistent selling and XLMs underperformance are driving a largely bearish discussion, with traders pointing to failed rebounds and technical weakness while some holders see dips as buying opportunities. Bulls cite institutional tokenization developments, including DTCC-related plans, but skeptics argue that adoption may not translate into token demand or price gains without improved tokenomics.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intels weaker-than-expected outlook after earnings, citing supply constraints and softer PC demand, drove a historic selloff. Traders are divided between viewing the plunge as an overreaction and warning of further downside, with execution and foundry customer concerns adding to the debate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CENX oversold like a mf. Total bs really.